Dexrazoxane
CAS No. 24584-09-6
Dexrazoxane ( ICRF-187;NSC-169780 )
Catalog No. M13714 CAS No. 24584-09-6
A derivative of EDTA that chelates iron and reduces the number of metal ions complexed with anthracycline and, consequently, decrease the formation of superoxide radicals.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 35 | Get Quote |
|
50MG | 51 | Get Quote |
|
100MG | 73 | Get Quote |
|
500MG | 180 | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDexrazoxane
-
NoteResearch use only, not for human use.
-
Brief DescriptionA derivative of EDTA that chelates iron and reduces the number of metal ions complexed with anthracycline and, consequently, decrease the formation of superoxide radicals.
-
DescriptionA derivative of EDTA that chelates iron and reduces the number of metal ions complexed with anthracycline and, consequently, decrease the formation of superoxide radicals; protects the heart against the cardiotoxic side effects of chemotherapeutic drugs.Chemotherapeutic Agents Approved
-
SynonymsICRF-187;NSC-169780
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research AreaCancer
-
IndicationChemotherapeutic
Chemical Information
-
CAS Number24584-09-6
-
Formula Weight268.27
-
Molecular FormulaC11H16N4O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESC[C@H](N(C1)CC(NC1=O)=O)CN(C2)CC(NC2=O)=O
-
Chemical Name2,6-Piperazinedione, 4,4'-[(1S)-1-methyl-1,2-ethanediyl]bis-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Lipshultz SE, et al. N Engl J Med. 2004 Jul 8;351(2):145-53.
2. Bjelogrlic SK, et al. Exp Biol Med (Maywood). 2007 Dec;232(11):1414-24.
3. Jones RL, et al. Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1311-7.
2. Bjelogrlic SK, et al. Exp Biol Med (Maywood). 2007 Dec;232(11):1414-24.
3. Jones RL, et al. Expert Rev Cardiovasc Ther. 2008 Nov;6(10):1311-7.
molnova catalog
related products
-
m-PEG9-SH
m-PEG9-SH is a PEG-based PROTAC linker that can be used in the synthesis of PROTAC.
-
Arjunglucoside I
Arjunglucoside I has anti-inflammatory activity, it exhibits significant activity against carrageenan-induced paw edema in rat.
-
Phthalic Acid Monooc...
Used as pharmaceutical intermediates.